US 10450372
Anti-thyroglobulin T cell receptors
granted A61KA61K2039/5156A61K38/00
Quick answer
US patent 10450372 (Anti-thyroglobulin T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/5156, A61K38/00, A61K39/001144, A61P